Virtu Financial LLC Bei Gene, Ltd. Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$158.67 - $201.58 $409,368 - $520,076	2,580 Added 94.19%	5,319 $959,000
Q3 2023 Nov 14, 2023	SELL	$179.87 - $225.13 $509,032 - $637,117	-2,830 Reduced 50.82%	2,739 $493,000
Q2 2023 Jul 27, 2023	BUY	$178.3 - $266.78 $992,952 - $1.49 Million	5,569 New	5,569 $993,000
Q2 2022 Aug 09, 2022	BUY	$121.11 - $216.05 $1.18 Million - $2.11 Million	9,758 New	9,758 $1.58 Million
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $904,051 - $1.46 Million	-3,622 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$292.75 - $367.01 $1.06 Million - $1.33 Million	3,622 New	3,622 $1.24 Million
Q2 2020 Aug 07, 2020	SELL	$123.9 - $195.41 $552,841 - $871,919	-4,462 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$115.78 - $208.34 $516,610 - $929,613	4,462 New	4,462 $740,000
Q3 2018 Nov 13, 2018	SELL	$152.62 - $189.66 $210,157 - $261,161	-1,377 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$152.5 - $216.77 $316,895 - $450,448	-2,078 Reduced 60.14%	1,377 $212,000
Q2 2018 Jul 30, 2018	BUY	$152.5 - $216.77 $526,887 - $748,940	3,455 New	3,455 $531,000
Q4 2017 Feb 09, 2018	SELL	$79.6 - $114.73 $300,649 - $433,335	-3,777 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$66.19 - $103.46 $249,999 - $390,768	3,777	3,777 $391,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.